Richard Leigh

10.8k total citations · 3 hit papers
140 papers, 7.5k citations indexed

About

Richard Leigh is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Immunology and Allergy. According to data from OpenAlex, Richard Leigh has authored 140 papers receiving a total of 7.5k indexed citations (citations by other indexed papers that have themselves been cited), including 92 papers in Physiology, 87 papers in Pulmonary and Respiratory Medicine and 24 papers in Immunology and Allergy. Recurrent topics in Richard Leigh's work include Asthma and respiratory diseases (90 papers), Respiratory and Cough-Related Research (43 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (30 papers). Richard Leigh is often cited by papers focused on Asthma and respiratory diseases (90 papers), Respiratory and Cough-Related Research (43 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (30 papers). Richard Leigh collaborates with scholars based in Canada, United States and United Kingdom. Richard Leigh's co-authors include Paul M. O’Byrne, David Proud, Robert Newton, Louis‐Philippe Boulet, Gail M. Gauvreau, Leanne M. Ward, Jacques P. Brown, Albert Cohen, Harold Kim and Alexandra Ahmet and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Richard Leigh

137 papers receiving 7.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy

2013 857 citations Dora Liu, Alexandra Ahmet et al. Allergy Asthma and Clinical Immunology profile →
Effects of an Anti-TSLP Antibody on Allergen-Induced Asthmatic Responses

2014 587 citations Gail M. Gauvreau, Paul M. O’Byrne et al. profile →
Effects of benralizumab on airway eosinophils in asthmatic patients with sputum eosinophilia

2013 370 citations Gail M. Gauvreau, Richard Leigh et al. profile →

Peers

Countries citing papers authored by Richard Leigh

Since Specialization

Citations

This map shows the geographic impact of Richard Leigh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Leigh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Leigh more than expected).

Fields of papers citing papers by Richard Leigh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Leigh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Leigh. The network helps show where Richard Leigh may publish in the future.

Co-authorship network of co-authors of Richard Leigh

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Leigh. A scholar is included among the top collaborators of Richard Leigh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Leigh. Richard Leigh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Inhaled anti-TSLP antibody fragment, ecleralimab, blocks responses to allergen in mild asthma 2023 ·European Respiratory Journal ·Gail M. Gauvreau, Jens M. Hohlfeld, J. Mark FitzGerald, Louis‐Philippe Boulet, Donald W. Cockcroft, Beth E. Davis, Stephanie Korn, Oliver Kornmann, Richard Leigh, Irvin Mayers, Henrik Watz, Sarah Schmidt Grant, Monish Jain, Maciej Cabanski, Peter Pertel, Ieuan Jones, (unknown), Hui Cao, Paul M. O’Byrne	40
2	Synergy between Interleukin-1β, Interferon-γ, and Glucocorticoids to Induce TLR2 Expression Involves NF-κB, STAT1, and the Glucocorticoid Receptor 2023 ·Molecular Pharmacology ·(unknown), Cora Kooi, (unknown), (unknown), (unknown), (unknown), (unknown), Mahmoud Mostafa, (unknown), Richard Leigh, Robert Newton	5
3	Optimizing COPD Acute Care Patient Outcomes Using a Standardized Transition Bundle and Care Coordinator 2022 ·CHEST Journal ·(unknown), Mohit Bhutani, Maria B. Ospina, Brian H. Rowe, Richard Leigh, (unknown), Peter Faris, (unknown), Kelly Mrklas, J. H. Graham, (unknown), Ronald W. Damant, Lee A. Green, Naushad Hirani, (unknown), Virginia Meyer, Patrick Mitchell, Willis H. Tsai, Brandie Walker, Michael K. Stickland	13
4	Sounding the alarmins—The role of alarmin cytokines in asthma 2022 ·Allergy ·Gail M. Gauvreau, Céline Bergeron, Louis‐Philippe Boulet, Donald W. Cockcroft, Andréanne Côté, Beth E. Davis, Richard Leigh, (unknown), Paul M. O’Byrne, Roma Sehmi	63
5	Transcriptome-Level Interactions between Budesonide and Formoterol Provide Insight into the Mechanism of Action of Inhaled Corticosteroid/Long-Acting β2-Adrenoceptor Agonist Combination Therapy in Asthma 2020 ·Molecular Pharmacology ·Mahmoud Mostafa, Christopher F. Rider, (unknown), Richard Leigh, Mark A. Giembycz, Robert Newton	7
6	Co-occurrence of Asthma and the Inflammatory Bowel Diseases: A Systematic Review and Meta-analysis 2018 ·Clinical and Translational Gastroenterology ·M Ellen Kuenzig, Kirles Bishay, Richard Leigh, Gilaad G. Kaplan, Eric I. Benchimol	61
7	Blood Flow during Handgrip Exercise in COPD 2015 ·Medicine & Science in Sports & Exercise ·Sara E. Hartmann, Xavier Waltz, Richard Leigh, Todd J. Anderson, Marc J. Poulin	10
8	A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy breakdown → 2013 ·Allergy Asthma and Clinical Immunology ·Dora Liu, Alexandra Ahmet, Leanne M. Ward, Preetha Krishnamoorthy, Efrem D. Mandelcorn, Richard Leigh, Jacques P. Brown, Albert Cohen, Harold Kim	857
9	Ventilatory responses to exercise and CO2 after menopause in healthy women: Effects of age and fitness 2012 ·Respiratory Physiology & Neurobiology ·Margie H. Davenport, Andrew E. Beaudin, Allison Brown, Richard Leigh, Marc J. Poulin	6
10	β ₂ -Adrenoceptor agonist-induced RGS2 expression is a genomic mechanism of bronchoprotection that is enhanced by glucocorticoids 2011 ·Proceedings of the National Academy of Sciences ·Neil S. Holden, (unknown), Christopher F. Rider, Elizabeth M. King, (unknown), Richard Leigh, Malcolm Johnson, David P. Siderovski, Scott P. Heximer, Mark A. Giembycz, Robert Newton	69
11	Canadian Thoracic Society Asthma Management Continuum – 2010 Consensus Summary for Children Six Years of Age and Over, and Adults 2010 ·Canadian Respiratory Journal ·M. Diane Lougheed, Catherine Lemière, Sharon Dell, Francine M. Ducharme, J. Mark FitzGerald, Richard Leigh, Chris Licskai, Brian H. Rowe, Dennis Bowie, Allan B. Becker, Louis‐Philippe Boulet	150
12	CHRONIC COUGH IS A WOMAN'S ISSUE 2009 ·CHEST Journal ·Stephen K. Field, (unknown), (unknown), Richard Leigh, Robert Cowie	0
13	Stable COPD: predicting benefit from high-dose inhaled corticosteroid treatment 2006 ·European Respiratory Journal ·Richard Leigh, Márcia Margaret Menezes Pizzichini, Michael J. Morris, François Maltais, Frederick E. Hargreave, Emílio Pizzichini	210
14	Acetazolamide reduces hypoxic pulmonary vasoconstriction in humans 2006 ·The FASEB Journal ·George M. Balanos, Luc J. Teppema, Craig D. Steinback, Allison Brown, Glen E. Foster, Richard Leigh, Marc J. Poulin	2
15	Is Interleukin-13 Critical in Maintaining Airway Hyperresposiveness in Allergen-challenged Mice? 2004 ·American Journal of Respiratory and Critical Care Medicine ·Richard Leigh, Russ Ellis, Jennifer Wattie, Debra D. Donaldson, Mark D. Inman	53
16	Type 2 Cytokines in the Pathogenesis of Sustained Airway Dysfunction and Airway Remodeling in Mice 2004 ·American Journal of Respiratory and Critical Care Medicine ·Richard Leigh, Russ Ellis, Jennifer Wattie, Jeremy A. Hirota, Klaus I. Matthaei, Paul S. Foster, Paul M. O’Byrne, Mark D. Inman	143
17	Effect of Interferon- γ on Allergic Airway Responses in Interferon- γ –deficient Mice 2002 ·American Journal of Respiratory and Critical Care Medicine ·Makoto Yoshida, Richard Leigh, Koichiro Matsumoto, Jennifer Wattie, Russ Ellis, Paul M. O’Byrne, Mark D. Inman	65
18	Effects of Montelukast and Budesonide on Airway Responses and Airway Inflammation in Asthma 2002 ·American Journal of Respiratory and Critical Care Medicine ·Richard Leigh, Dilini Vethanayagam, Makoto Yoshida, Richard M. Watson, Tracy Rerecich, Mark D. Inman, Paul M. O’Byrne	105
19	Induced Sputum Cell Counts in Healthy Adults 2000 ·American Journal of Respiratory and Critical Care Medicine ·J. Belda, Richard Leigh, Krishnan Parameswaran, Paul M. O’Byrne, Malcolm R. Sears, F. E. Hargreave	312
20	Induced Sputum, Eosinophilic Bronchitis, and Chronic Obstructive Pulmonary Disease 1999 ·American Journal of Respiratory and Critical Care Medicine ·F. E. Hargreave, Richard Leigh	64

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact